Daiqiang M. Li
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study.
Journal: Cancer communications (London, England)
Published: February 01, 2024
De novo DCHS1 splicing mutation in a patient with mitral valve prolapse.
Journal: QJM : monthly journal of the Association of Physicians
Published: June 24, 2022
FOXP1 and FOXO3a Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: March 30, 2022
BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
Journal: Technology in cancer research & treatment
Published: November 25, 2020
Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images-The ACDC@LungHP Challenge 2019.
Journal: IEEE journal of biomedical and health informatics
Published: November 20, 2020
The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance.
Journal: The American journal of the medical sciences
Published: September 22, 2020
Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
Journal: Medicine
Published: September 22, 2020
Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance.
Journal: Biomarkers in medicine
Published: September 22, 2020
Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
Journal: Analytical cellular pathology (Amsterdam)
Published: April 07, 2020
Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer.
Journal: Frontiers in oncology
Published: February 22, 2020
XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer.
Journal: Frontiers in molecular biosciences
Published: February 19, 2020
Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: February 12, 2020
Last Updated: 09/26/2026